We recently showed that indapamide (IDP), a thiazide-related diuretic, incr
eases bone mass and decreases bone resorption in spontaneously hypertensive
rats supplemented with sodium. In the present study, we evaluated the in v
itro effects of this diuretic on bone cells, as well as those of hydrochlor
othiazide (HCTZ), the reference thiazide, and acetazolamide (AZ), a carboni
c anhydrase (CA) inhibitor. We showed that 10(-4) M IDP and 10(-4) M AZ, as
well as 10(-5) M pamidronate (APD), decreased bone resorption in organ cul
tures and in cocultures of osteoblast-like cells and bone marrow cells in t
he presence of 10(-8) M 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3]. We inve
stigated the mechanism of this antiresorptive effect of IDP; IDP decreased
osteoclast differentiation as the number of osteoclasts developing in cocul
ture of marrow and osteoblast-like cells was decreased markedly. We then in
vestigated whether IDP affected osteoblast-like cells because these cells a
re involved in the osteoclast differentiation. Indeed, IDP increased osteob
last-like cell proliferation and alkaline phosphatase (ALP) expression. Nev
ertheless, it did not modify the colony-stimulating factor 1 (CSF-1) produc
tion by these cells. In addition, osteoblast-like cells expressed the Na+/C
l- cotransporter that is necessary for the renal action of thiazide diureti
cs, but IDP inhibited bone resorption in mice lacking this cotransporter, s
o the inhibition of bone resorption and osteoclast differentiation did not
involve this pathway. Thus, we hypothesized that IDP may act directly on ce
lls of the osteoclast lineage. We observed that resorption pits produced by
spleen cells cultured in the presence of soluble osteoclast differentiatio
n factor (sODF) and CSF-1 were decreased by 10(-4) M IDP as well as 10(-5)
M APD. In conclusion, in vitro IDP increased osteoblast proliferation and d
ecreased bone resorption at least in part by decreasing osteoclast differen
tiation via a direct effect on hematopoietic precursors.